Ontology highlight
ABSTRACT: Unlabelled
Accumulating evidence demonstrates that microRNA-29 (miR-29) expression is prominently decreased in patients with hepatic fibrosis, which consequently stimulates hepatic stellate cells' (HSCs) activation. We used a cDNA microarray study to gain a more comprehensive understanding of genome-wide gene expressions by adjusting miR-29a expression in a bile duct-ligation (BDL) animal model.Methods
Using miR-29a transgenic mice and wild-type littermates and applying the BDL mouse model, we characterized the function of miR-29a with regard to cholestatic liver fibrosis. Pathway enrichment analysis and/or specific validation were performed for differentially expressed genes found within the comparisons.Results
Analysis of the microarray data identified a number of differentially expressed genes due to the miR-29a transgene, BDL, or both. Additional pathway enrichment analysis revealed that TGF-? signaling had a significantly differential activated pathway depending on the occurrence of miR-29a overexpression or the lack thereof. Furthermore, overexpression was found to elicit changes in Wnt/?-catenin after BDL.Conclusion
This study verified that an elevated miR-29a level could alleviate liver fibrosis caused by cholestasis. Furthermore, the protective effects of miR-29a correlate with the downregulation of TGF-? and associated with Wnt/?-catenin signal pathway following BDL.
SUBMITTER: Li SC
PROVIDER: S-EPMC4813186 | biostudies-literature | 2016 Mar
REPOSITORIES: biostudies-literature
Li Sung-Chou SC Wang Feng-Sheng FS Yang Ya-Ling YL Tiao Mao-Meng MM Chuang Jiin-Haur JH Huang Ying-Hsien YH
International journal of molecular sciences 20160301 3
<h4>Unlabelled</h4>Accumulating evidence demonstrates that microRNA-29 (miR-29) expression is prominently decreased in patients with hepatic fibrosis, which consequently stimulates hepatic stellate cells' (HSCs) activation. We used a cDNA microarray study to gain a more comprehensive understanding of genome-wide gene expressions by adjusting miR-29a expression in a bile duct-ligation (BDL) animal model.<h4>Methods</h4>Using miR-29a transgenic mice and wild-type littermates and applying the BDL m ...[more]